logo

United Therapeutics Corp (UTHR) Stock: Uncovering a 52-Week Range and Trading Volume

VIPS stock

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. United Therapeutics Corp’s current trading price is -12.26% away from its 52-week high, while its distance from the 52-week low is 75.73%. The stock’s price range during this period has varied between $208.62 and $417.82. The company, active in the Healthcare sector, saw a trading volume of around 0.25 million for the day, considerably lower average daily volume of 0.32 million observed over the last three months.

United Therapeutics Corp’s stock has had a calm market performance. The 1-year high for the company’s stock was $417.82 on 11/08/24, and the lowest price during the same period was recorded at $208.62 on 02/08/24.

How Financial Performance Impacts Market Capitalization

United Therapeutics Corp (UTHR) has experienced a quarterly rise of 3.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 16.37B and boasts a workforce of 1168 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 361.71, with a change in price of +43.53. Similarly, United Therapeutics Corp recorded 357,214 in trading volume during the last 100 days, posting a change of +13.47%.

How UTHR’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for UTHR stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.00.

UTHR Stock Stochastic Average

As of today, the raw stochastic average of United Therapeutics Corp over the past 50 days is 31.03%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 49.41%. Additionally, the Stochastic %K and %D values for the company were 33.47% and 25.69%, respectively, over the past 20 days.

UTHR Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 3.90% this year. Over the last six months, there has been a weaker performance of 11.35%. The price of UTHR leaped by -0.83% during the last 30 days period. For the last 5-days stocks have improved 3.90%.

Most Popular